Avestar Capital’s Exelixis EXEL Stock Holding History

Avestar Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-897	Closed	-$19K	–	394
2019 Q2	$19K	Buy	897 +251	+39%	+$5.26K	0.01%	398
2019 Q1	$15K	Buy	646 +154	+31%	+$3.51K	0.01%	413
2018 Q4	$9K	Buy	+492	New	+$8.77K	0.01%	451

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Avestar Capital's EXEL Position: Q3 2019 in Review

Avestar Capital sold out of Exelixis (EXEL) in Q3 2019, closing a stake of 897 shares — an estimated $19K sold.

Avestar Capital first reported a position in EXEL in Q4 2018 and held it in 3 quarters. The position peaked at $19K in Q2 2019. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.

Avestar Capital reported no remaining Exelixis position as of Q3 2019 after selling out during the quarter.
Avestar Capital sold 897 Exelixis shares in Q3 2019, an estimated $19K.
Avestar Capital first reported a position in Exelixis in Q4 2018 and held it in 3 quarters.
Avestar Capital's Exelixis position peaked at $19K in Q2 2019.
339 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.